Palepu; Nagesh R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Palepu; Nagesh R..The latest application filed is for "fulvestrant formulations".
Company Profile
4.23.30
- Palepu; Nagesh R. - Southampton PA
- Palepu; Nagesh R. - Southhampton PA US
- PALEPU; Nagesh R. - South Hampton PA
Patent Activity
| Patent | Date |
|---|---|
| Fulvestrant Formulations App 20220072132 - Teja; Bulusu Bhanu ; et al. | 2022-03-10 |
| Formulations Of Bendamustine App 20210393594 - Palepu; Nagesh R. ; et al. | 2021-12-23 |
| Fulvestrant formulations Grant 11,179,468 - Teja , et al. November 23, 2 | 2021-11-23 |
| Formulations of bendamustine Grant 11,103,483 - Palepu , et al. August 31, 2 | 2021-08-31 |
| In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid Grant 11,096,949 - Palepu August 24, 2 | 2021-08-24 |
| Formulations Of Vancomycin App 20210236592 - Palepu; Nagesh R. ; et al. | 2021-08-05 |
| In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin) Grant 10,959,955 - Palepu March 30, 2 | 2021-03-30 |
| Formulations of vancomycin Grant 10,864,250 - Palepu , et al. December 15, 2 | 2020-12-15 |
| In-vial Deposition Of A Stable, Sterile And Crystalline O-acetyl Salicylic Acid (aspirin) App 20200188417 - PALEPU; Nagesh R. | 2020-06-18 |
| Formulations Of Bendamustine App 20190350904 - Palepu; Nagesh R. ; et al. | 2019-11-21 |
| Formulations Of Vancomycin App 20190336570 - Palepu; Nagesh R. ; et al. | 2019-11-07 |
| Formulations of vancomycin Grant 10,376,559 - Palepu , et al. A | 2019-08-13 |
| Formulations Of Bendamustine App 20180296535 - Palepu; Nagesh R. ; et al. | 2018-10-18 |
| Formulations Of Bendamustine App 20180296536 - Palepu; Nagesh R. ; et al. | 2018-10-18 |
| Formulations of bendamustine Grant 10,010,533 - Palepu , et al. July 3, 2 | 2018-07-03 |
| Formulations Of Bendamustine App 20180000789 - Palepu; Nagesh R. ; et al. | 2018-01-04 |
| Formulations Of Cyclophosphamide Liquid Concentrate App 20170232015 - Palepu; Nagesh R. ; et al. | 2017-08-17 |
| Formulations Of Vancomycin App 20170224767 - Palepu; Nagesh R. ; et al. | 2017-08-10 |
| Formulations of cyclophosphamide liquid concentrate Grant 9,662,342 - Palepu , et al. May 30, 2 | 2017-05-30 |
| Pharmaceutical compositions containing pemetrexed having extended storage stability Grant 9,655,898 - Palepu , et al. May 23, 2 | 2017-05-23 |
| Formulations of vancomycin Grant 9,616,098 - Palepu April 11, 2 | 2017-04-11 |
| Formulations of bendamustine Grant 9,572,796 - Palepu , et al. February 21, 2 | 2017-02-21 |
| Formulations of bendamustine Grant 9,572,797 - Palepu , et al. February 21, 2 | 2017-02-21 |
| Formulations Of Bendamustine App 20160143888 - Palepu; Nagesh R. ; et al. | 2016-05-26 |
| Formulations Of Bendamustine App 20160143887 - Palepu; Nagesh R. ; et al. | 2016-05-26 |
| Formulations Of Vancomycin App 20160101147 - PALEPU; Nagesh R. | 2016-04-14 |
| Formulations of bendamustine Grant 9,265,831 - Palepu , et al. February 23, 2 | 2016-02-23 |
| Enema composition for treatment of ulcerative colitis having long term stability Grant 9,238,037 - Palepu , et al. January 19, 2 | 2016-01-19 |
| Formulations Of Cyclophosphamide Liquid Concentrate App 20150320774 - PALEPU; Nagesh R. ; et al. | 2015-11-12 |
| Formulations Of Cyclophosphamide Liquid Concentrate App 20150320775 - PALEPU; Nagesh R. ; et al. | 2015-11-12 |
| Enema Composition For Treatment Of Ulcerative Colitis Having Long Term Stability App 20140323449 - PALEPU; Nagesh R. ; et al. | 2014-10-30 |
| Enema composition for treatment of ulcerative colitis having long term stability Grant 8,809,308 - Palepu , et al. August 19, 2 | 2014-08-19 |
| Enema Composition For Treatment Of Ulcerative Colitis Having Long Term Stability App 20140135299 - PALEPU; Nagesh R. ; et al. | 2014-05-15 |
| Formulations Of Bendamustine App 20140024691 - Palepu; Nagesh R. ; et al. | 2014-01-23 |
| Formulations of bendamustine Grant 8,609,707 - Palepu , et al. December 17, 2 | 2013-12-17 |
| Epoprostenol formulation and method of making thereof Grant 8,598,227 - Palepu December 3, 2 | 2013-12-03 |
| Fulvestrant Formulations App 20130267489 - Teja; Bulusu Bhanu ; et al. | 2013-10-10 |
| Pharmaceutical Compositions Containing Pemetrexed Having Extended Storage Stability App 20130231357 - Palepu; Nagesh R. ; et al. | 2013-09-05 |
| Formulations Of Bendamustine App 20130210879 - Palepu; Nagesh R. ; et al. | 2013-08-15 |
| Formulations of daptomycin Grant 8,431,539 - Palepu , et al. April 30, 2 | 2013-04-30 |
| Formulations Of Bendamustine App 20110184036 - Palepu; Nagesh R. ; et al. | 2011-07-28 |
| Formulations Of Daptomycin App 20110172167 - Palepu; Nagesh R. ; et al. | 2011-07-14 |
| Formulations Of Daptomycin App 20110124551 - Palepu; Nagesh R. ; et al. | 2011-05-26 |
| Bioenhanced Compositions App 20100119607 - PALEPU; Nagesh R. ; et al. | 2010-05-13 |
| Topotecan Ready To Use Solutions App 20090221622 - TEJA; Bulusu Bhanu ; et al. | 2009-09-03 |
| Novel Epoprostenol Formulation And Method Of Making Thereof App 20090088468 - Palepu; Nagesh R. | 2009-04-02 |
| Stable pharmaceutical compositions, processes for making the same and methods of their use Grant 7,429,390 - Palepu September 30, 2 | 2008-09-30 |
| Stable Pharmaceutical Compositions, Processes For Making The Same And Methods Of Their Use App 20070190085 - PALEPU; Nagesh R. | 2007-08-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 